HemOnc.org：肿瘤学专业人员的协作在线知识平台。
HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals.
作者信息
Warner Jeremy L, Cowan Andrew J, Hall Aric C, Yang Peter C
机构信息
Vanderbilt University, Nashville, TN; Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA; University of Wisconsin School of Medicine and Public Health, Madison, WI; Massachusetts General Hospital, Boston, MA
Vanderbilt University, Nashville, TN; Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA; University of Wisconsin School of Medicine and Public Health, Madison, WI; Massachusetts General Hospital, Boston, MA.
出版信息
J Oncol Pract. 2015 May;11(3):e336-50. doi: 10.1200/JOP.2014.001511. Epub 2015 Mar 3.
PURPOSE
Cancer care involves extensive knowledge about numerous chemotherapy drugs and chemotherapy regimens. This information is constantly evolving, and there has been no freely available, comprehensive, centralized repository of chemotherapy information to date.
METHODS
We created an online, freely accessible, ad-free, collaborative wiki of chemotherapy information entitled HemOnc.org to address the unmet need for a central repository of this information. This Web site was developed with wiki development software and is hosted on a cloud platform. Chemotherapy drug and regimen information (including regimen variants), as well as other information of interest to hematology/oncology professionals, is housed on the site in a fully referenced and standardized format. Accredited users are allowed to freely contribute information to the site.
RESULTS
From its inception in November 2011, HemOnc.org has grown rapidly and most recently has detailed information on 383 drugs and 1,298 distinct chemotherapy regimens (not counting variants) in 92 disease subtypes. There are regularly more than 2,000 visitors per week from the United States and international locations. A user evaluation demonstrated that users find the site useful, usable, and recommendable.
CONCLUSION
HemOnc.org is now the largest free source of chemotherapy drug and regimen information and is widely used. Future enhancements, including more metadata about drugs and increasingly detailed efficacy and toxicity information, will continue to improve the value of the resource.
目的
癌症治疗涉及大量关于多种化疗药物和化疗方案的知识。这些信息不断更新，而迄今为止尚无免费可用的、全面的、集中的化疗信息库。
方法
我们创建了一个名为HemOnc.org的在线、免费访问、无广告的化疗信息协作维基，以满足对该信息中央存储库的未满足需求。该网站使用维基开发软件构建，并托管在云平台上。化疗药物和方案信息（包括方案变体）以及血液学/肿瘤学专业人员感兴趣的其他信息以完全参考和标准化的格式存储在该网站上。经认证的用户可以自由向该网站贡献信息。
结果
自2011年11月创建以来，HemOnc.org发展迅速，最近详细介绍了92种疾病亚型中的383种药物和1298种不同的化疗方案（不包括变体）。每周有来自美国和其他国家的2000多名访客。用户评估表明，用户认为该网站有用、易用且值得推荐。
结论
HemOnc.org现在是最大的免费化疗药物和方案信息来源，且被广泛使用。未来的改进，包括更多关于药物的元数据以及日益详细的疗效和毒性信息，将继续提升该资源的价值。
Zotero 插件